Literature DB >> 7848914

Functional characterization of two cholecystokinin-B/gastrin receptor isoforms: a preferential splice donor site in the human receptor gene.

M Ito1, N Iwata, T Taniguchi, T Murayama, K Chihara, T Matsui.   

Abstract

The cholecystokinin-B and gastrin receptor is encoded by a single gene composed of five exons and spanning over 10 kilobases on human chromosome 11p 15.5-->15.4. Exon 4 has two possible alternative splicing donor sites that seem to be conserved in other species such as the canine, rat, Mastomys, and mouse. They could generate two receptor isoforms (short- and long-form), which differ in their putative third cytoplasmic domain of the serpentine G-protein-coupled receptors. In the present study, we examined whether an alternative splicing is operated in a tissue-specific manner and whether two receptor isoforms have functional differences. RNase-protection assay and S1 nuclease mapping demonstrated the preferential expression of the short-form in the human brain as well as the digestive organs, stomach and pancreas. The two putative isoforms of the cholecystokinin-B/gastrin receptor expressed in mouse fibroblasts showed the same characteristics in their ligand-bindings, the major signal transduction such as phosphoinositides production, cytoplasmic Ca2+ increase, tyrosine phosphorylation of focal adhesion kinase, activation of mitogen-activated protein kinase, and the induction of early-responsive genes such as c-fos, c-myc, and c-jun. Moreover, the ligand-dependent trophic effect was seen in both receptor isoforms. Taken together with the absence of tissue-specific expression of two receptor isoforms, these results suggest a species-specific dominant splice donor site in exon 4 of the human receptor gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7848914

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  11 in total

1.  Pharmacological comparison of the alternatively spliced short and long CCK2 receptors.

Authors:  M F Morton; E A Harper; I A Tavares; N P Shankley
Journal:  Br J Pharmacol       Date:  2003-08-04       Impact factor: 8.739

2.  Thermodynamic analysis of ligands at cholecystokinin CCK2 receptors in rat cerebral cortex.

Authors:  E A Harper; S P Roberts; S B Kalindjian
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

3.  Species-specific regulation of alternative splicing in the C-terminal region of the p53 tumor suppressor gene.

Authors:  M Laverdière; J Beaudoin; A Lavigueur
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

4.  Characterization of the binding of a novel radioligand to CCKB/gastrin receptors in membranes from rat cerebral cortex.

Authors:  E A Harper; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

5.  Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex.

Authors:  E A Harper; E P Griffin; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

6.  Pharmacological analysis of the CCKB/gastrin receptors mediating pentagastrin-stimulated gastric acid secretion in the isolated stomach of the immature rat.

Authors:  D M Hills; V P Gerskowitch; S P Roberts; N J Welsh; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

7.  Proliferative effects of cholecystokinin in GH3 pituitary cells mediated by CCK2 receptors and potentiated by insulin.

Authors:  A J Smith; R M McKernan
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

8.  A comparison of the therapeutic effectiveness of gastrin neutralisation in two human gastric cancer models: relation to endocrine and autocrine/paracrine gastrin mediated growth.

Authors:  S A Watson; T M Morris; A Varro; D Michaeli; A M Smith
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

Review 9.  Gastrin - active participant or bystander in gastric carcinogenesis?

Authors:  Susan A Watson; Anna M Grabowska; Mohamad El-Zaatari; Arjun Takhar
Journal:  Nat Rev Cancer       Date:  2006-12       Impact factor: 60.716

10.  Coexpression of gastrin and gastrin receptors (CCK-B and delta CCK-B) in gastrointestinal tumour cell lines.

Authors:  D F McWilliams; S A Watson; D M Crosbee; D Michaeli; R Seth
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.